Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT vs. Sertraline in PTSD
NCT00391430Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- May 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sertraline in post-traumatic stress disorder (PTSD) (3 arms), sponsored by NYU Langone Health. Primary endpoints: Salivary Cortisol Levels and Fear Response. Started May 2005; status: terminated.
02
Drugs
sertraline
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00391430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391430.